Abstract:The optimization of therapeutic antibodies through traditional techniques, such as candidate screening via hybridoma or phage display, is resource-intensive and time-consuming. In recent years, computational and artificial intelligence-based methods have been actively developed to accelerate and improve the development of therapeutic antibodies. In this study, we developed an end-to-end sequence-based deep learning model, termed AttABseq, for the predictions of the antigen-antibody binding affinity changes connected with antibody mutations. AttABseq is a highly efficient and generic attention-based model by utilizing diverse antigen-antibody complex sequences as the input to predict the binding affinity changes of residue mutations. The assessment on the three benchmark datasets illustrates that AttABseq is 120% more accurate than other sequence-based models in terms of the Pearson correlation coefficient between the predicted and experimental binding affinity changes. Moreover, AttABseq also either outperforms or competes favorably with the structure-based approaches. Furthermore, AttABseq consistently demonstrates robust predictive capabilities across a diverse array of conditions, underscoring its remarkable capacity for generalization across a wide spectrum of antigen-antibody complexes. It imposes no constraints on the quantity of altered residues, rendering it particularly applicable in scenarios where crystallographic structures remain unavailable. The attention-based interpretability analysis indicates that the causal effects of point mutations on antibody-antigen binding affinity changes can be visualized at the residue level, which might assist automated antibody sequence optimization. We believe that AttABseq provides a fiercely competitive answer to therapeutic antibody optimization.

Attentive cross-modal paratope prediction

Neural message passing for joint paratope-epitope prediction

Prediction of Paratope–Epitope Pairs Using Convolutional Neural Networks

DeepANIS: Predicting antibody paratope from concatenated CDR sequences by integrating bidirectional long-short-term memory and transformer neural networks

ParaSurf: A Surface-Based Deep Learning Approach for Paratope-Antigen Interaction Prediction

Improving Paratope and Epitope Prediction by Multi-Modal Contrastive Learning and Interaction Informativeness Estimation

NanoBERTa-ASP: predicting nanobody paratope based on a pretrained RoBERTa model

Geometric epitope and paratope prediction

Striped-Cross Attention Network with Implicit Semantic Knowledge for Antibody Structure Prediction

MATE-Pred: Multimodal Attention-based TCR-Epitope interaction Predictor

A compact vocabulary of paratope-epitope interactions enables predictability of antibody-antigen binding

ANTIPASTI: Interpretable prediction of antibody binding affinity exploiting normal modes and deep learning

A unified cross-attention model for predicting antigen binding specificity to both HLA and TCR molecules

Exploiting the Role of Features for Antigens-Antibodies Interaction Site Prediction

AttABseq: an Attention-Based Deep Learning Prediction Method for Antigen-Antibody Binding Affinity Changes Based on Protein Sequences.

ATM-TCR: TCR-Epitope Binding Affinity Prediction Using a Multi-Head Self-Attention Model

A deep attention model for wide-genome protein-peptide binding affinity prediction at a sequence level

Conditional Antibody Design as 3D Equivariant Graph Translation